Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma-Reference-Cited by-同舟云学术

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma

Published:2015-04-21 Issue:8 Volume:137 Page:1947-1952
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Koskela-Niska Virpi¹,Pukkala Eero²³,Lyytinen Heli¹,Ylikorkala Olavi¹,Dyba Tadeusz²⁴

Affiliation:

1. Department of Obstetrics and Gynecology; Helsinki University Hospital; FI-00029 HUS Finland

2. Finnish Cancer Registry; Institute for Statistical and Epidemiological Cancer Research; Unioninkatu 20 Helsinki FI-00130 Finland

3. School of Health Sciences; FI-33014 University of Tampere; Finland

4. Public Health-Cancer Policy Support; European Commission DG Joint Research Centre, Institute for Health and Consumer Protection; Ispra I-21027 Italy

Funder

The National Graduate School of Clinical Investigation

Finnish Cancer Research Foundation

Finnish-Norwegian Medical Foundation

Finnish Medical Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. A candidate precursor to serous carcinoma that originates in the distal fallopian tube;Lee;J Pathol,2007

2. The distal fallopian tube: a new model for pelvic serous carcinogenesis;Crum;Curr Opin Obstet Gynecol,2007